Breaking Down the FDA’s Recent Update on Neuralink
Welcome, Reader, to a special edition of Smart Money, where we delve into the latest financial news and its implications. But first, let’s recap on last night’s enlightening event where we discussed:
- Steps to safeguard your portfolio without making new investments
- Opportunities to outperform the market
- Utilizing an alert system for potential gains and avoiding losses
If you missed the event, you can catch the replay here.
The Breakthrough Device: Neuralink’s Blindsight
Neuralink, Elon Musk’s neurotechnology company, recently received the FDA’s “breakthrough device” designation for their brain-computer interface (BCI) device, Blindsight. This innovative device aims to restore vision in patients who have lost both eyes and their optic nerve.
The Technology Behind Neuralink
- PRIME: Neuralink’s human clinical trial focusing on brain-computer interface technology
- N1: A wireless brain chip with over 1,000 electrodes attached to 64 threads for brain-reading capabilities
- R1: A surgeon-like robot that can insert all 64 threads in the brain in just 15 minutes
The N1 device interprets neural activity, allowing individuals with quadriplegia or ALS to control external devices with their mind. Neuralink’s successful implantations showcase the potential of this groundbreaking technology.
Understanding the FDA’s “Breakthrough Device” Designation
The FDA grants this designation to promising medical devices for serious conditions, expediting the approval process. While it doesn’t guarantee success, it indicates the FDA’s openness to Neuralink’s advancements like PRIME and Blindsight.
Investing in Neuralink’s Growth
Neuralink’s future plans include enhancing AI devices and increasing the number of implanted devices. The company’s potential to merge human and artificial intelligence positions it as a significant wealth creator.
Investors can explore opportunities to benefit from Neuralink’s success through certain tech companies and financial strategies. To learn more about profiting from Elon Musk’s Neuralink, check out the Fry’s Investment Report.
Stay informed and prepared for market uncertainties by accessing valuable insights and tools to protect your investments. Watch last night’s conversation with industry experts to navigate the current financial landscape effectively.